CCL5 and pulmonary arterial hypertension: Furthermore, SLE patients with severe PAH exhibit enhanced expression of various growth factors and chemokines such as RANTES/CCL5 and fractalkine/fractalkine (CX3CL1) within the pulmonary artery, emphasizing the complex interplay of factors involved in this condition.